Correlation of Age-Related Metabonomic Changes in 1H NMR Serum and Urine Profiles of Rats with Cognitive Function

Abstract

Age related metabonomic changes in young and aged male albino rats have been investigated using Proton Nuclear Magnetic Resonance ( 1 H NMR) spectroscopy. The studies were performed using 'in vivo' behavioral and metabonomic assessment in serum and urine of the rats. Significant changes (p<0.05) were obtained in the concentration of creatinine, allantoin and hippurate in urine. Also significant (p<0.05) alterations were also discernible in acetate, pyruvate, lactate, creatine and glucose in serum. Attempts have been made to correlate these changes with the cognitive impairment and perturbed energy metabolism in aged rats. The metabonomic evaluation of age related changes in serum and urine showed altered concentrations of many Krebs cycle intermediates in old rats. Likewise it was associated with diminished mitochondrial functioning. On the basis of our results it is suggested that the observed changes may be an early clinical indication of cognitive decline related to dementia.

An Investigation into the Antiobesity Effects ofMorinda citrifoliaL. Leaf Extract in High Fat Diet Induced Obese Rats Using a1H NMR Metabolomics Approach

“…The urine of Zucker rats and the serum of HFD mice also had lower lactate content than the normal weight rats and the serum [ 14 , 35 ]. The reduced lactate levels can be explained by factors other than HFD induced obesity, including young age and activity [ 36 ].…”

NMR metabolomics and drug discovery

“…NMR-based metabolomics have been used to identify biomarkers associated with a variety of diseases including asthma, [87] (a) (b) arthritis, [88] cancer, [89 -91] cardiovascular, [92] diabetes, [93 -95] neurodegenerative, [96,97] and pathogen infections. [98] As an illustration, a clinical study described by van Doorn et al [95] demonstrates the use of 1D 1 H NMR analysis of blood serum samples to distinguish between healthy volunteers and type 2 diabetes mellitus (T2DM) patients.…”